The success of continued steroid avoidance after kidney transplantation in the US

American Journal of Transplantation

Volumn 9, Issue 12, 2009, Pages 2768-2776

  Schold, J D ^a,b   Santos, A ^a   Rehman, S ^a   Magliocca, J ^b   Meier Kriesche, H U ^a  

^a Department of Surgery ^*  (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

Immunosuppressive regimens; Kidney transplantation; Outcomes; Steroid avoidance

Indexed keywords

ALEMTUZUMAB; BASILIXIMAB; CYCLOSPORIN; CYCLOSPORIN A; DACLIZUMAB; INTERLEUKIN 2 RECEPTOR BLOCKING AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RECEPTOR BLOCKING AGENT; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG;

ACUTE GRAFT REJECTION; AFRICAN AMERICAN; ARTICLE; CLINICAL TRIAL; DRUG USE; GRAFT SURVIVAL; HLA MATCHING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DONOR; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAINTENANCE THERAPY; MEDICAID; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SENSITIZATION; SOLITARY KIDNEY; SURVIVAL TIME;

CADAVER; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; RETROSPECTIVE STUDIES; RISK FACTORS; STEROIDS; TISSUE DONORS; TREATMENT OUTCOME; UNITED STATES;

EID: 72449205113     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2009.02838.x     Document Type: Article

References (10)

1. Meier-Kriesche HU, Schold JD, Kaplan B. Long-term renal allograft survival: Have we made significant progress or is it time to rethink our analytic and therapeutic strategies? Am J Transplant 2004 4 : 1289 1295.
2. Meier-Kriesche HU, Schold JD, Srinivas TR, Kaplan B. Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant 2004 4 : 378 383.
3. Srinivas TR, Meier-Kriesche HU. Minimizing immunosuppression, an alternative approach to reducing side effects: Objectives and interim result. Clin J Am Soc Nephrol 2008 3 (Suppl 2 S101 S116.
4. Gallon LG, Winoto J, Leventhal JR, Parker MA, Kaufman DB. Effect of prednisone versus no prednisone as part of maintenance immunosuppression on long-term renal transplant function. Clin J Am Soc Nephrol 2006 1 : 1029 1038.
5. Kaufman DB, Leventhal JR, Koffron AJ et al. A prospective study of rapid corticosteroid elimination in simultaneous pancreas-kidney transplantation: Comparison of two maintenance immunosuppression protocols: Tacrolimus/ mycophenolate mofetil versus tacrolimus/sirolimus. Transplantation 2002 73 : 169 177.
6. Humar A, Gillingham K, Kandaswamy R, Payne W, Matas A. Steroid avoidance regimens: A comparison of outcomes with maintenance steroids versus continued steroid avoidance in recipients having an acute rejection episode. Am J Transplant 2007 7 : 1948 1953.
7. Woodle ES, First MR, Pirsch J, Shihab F, Gaber AO, Van VP. A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy. Ann Surg 2008 248 : 564 577.
8. Vincenti F, Schena FP, Paraskevas S, Hauser IA, Walker RG, Grinyo J. A randomized, multicenter study of steroid avoidance, early steroid withdrawal or standard steroid therapy in kidney transplant recipients. Am J Transplant 2008 8 : 307 316.
9. Opelz G, Dohler B, Laux G. Long-term prospective study of steroid withdrawal in kidney and heart transplant recipients. Am J Transplant 2005 5 : 720 728.
10. Luan FL, Steffick DE, Gadegbeku C, Norman SP, Wolfe R, Ojo AO. Graft and patient survival in kidney transplant recipients selected for de novo steroid-free maintenance immunosuppression. Am J Transplant 2009 9 : 160 168.